miR-22 represses cancer progression by inducing cellular senescence |
| |
Authors: | Xu Dan Takeshita Fumitaka Hino Yumiko Fukunaga Saori Kudo Yasusei Tamaki Aya Matsunaga Junko Takahashi Ryou-U Takata Takashi Shimamoto Akira Ochiya Takahiro Tahara Hidetoshi |
| |
Institution: | 1Department of Cellular and Molecular Biology, and 2Department of Oral Maxillofacial Pathobiology, Graduate School of Biomedical Science, Hiroshima University, Minami-ku, Hiroshima 734-8553, Japan;3Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan |
| |
Abstract: | Cellular senescence acts as a barrier to cancer progression, and microRNAs (miRNAs) are thought to be potential senescence regulators. However, whether senescence-associated miRNAs (SA-miRNAs) contribute to tumor suppression remains unknown. Here, we report that miR-22, a novel SA-miRNA, has an impact on tumorigenesis. miR-22 is up-regulated in human senescent fibroblasts and epithelial cells but down-regulated in various cancer cell lines. miR-22 overexpression induces growth suppression and acquisition of a senescent phenotype in human normal and cancer cells. miR-22 knockdown in presenescent fibroblasts decreased cell size, and cells became more compact. miR-22-induced senescence also decreases cell motility and inhibits cell invasion in vitro. Synthetic miR-22 delivery suppresses tumor growth and metastasis in vivo by inducing cellular senescence in a mouse model of breast carcinoma. We confirmed that CDK6, SIRT1, and Sp1, genes involved in the senescence program, are direct targets of miR-22. Our study provides the first evidence that miR-22 restores the cellular senescence program in cancer cells and acts as a tumor suppressor. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|